About Molecule
Molecule is a company based in Houston (United States) founded in 2012 by Sameer Soleja. It operates as a SaaS (Software-as-a-Service) and Data-as-a-Service. Molecule has raised $14.34 million across 5 funding rounds from investors including Mercury Fund, Houston Angel Network and Surge Ventures. Molecule offers products and services including Molecule ETRM/CTRM Platform, Renewables Add-on, Physical Power Add-on, and Crypto Add-on. Molecule operates in a competitive market with competitors including OpenGamma, Realeyes, Moody's Analytics, Encompass and Indico Data, among others.
- Headquarter Houston, United States
- Founders Sameer Soleja
-
Sectors
Technology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Molecule Software, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$14.34 M (USD)
in 5 rounds
-
Latest Funding Round
Not available
-
Investors
Mercury Fund
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Molecule
Molecule offers a comprehensive portfolio of products and services, including Molecule ETRM/CTRM Platform, Renewables Add-on, Physical Power Add-on, and Crypto Add-on.
Cloud-based platform for energy trading risk management.
Manages lifecycle of renewable energy trade attributes.
Supports modeling and reporting for physical power trades.
Integrates crypto trading risk with energy portfolios.
People of Molecule
Unlock access to complete
Funding Insights of Molecule
Molecule has successfully raised a total of $14.34M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Molecule
Molecule has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Mercury Fund, Houston Angel Network and Surge Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are directed toward US, India, and Canada firms.
|
Locked | Locked | Locked | |
|
Houston Angel Network is focused on supporting startups with funding.
|
Locked | Locked | Locked | |
|
Venture capital services are extended to early-stage startups.
|
Locked | Locked | Locked |
Investor details for Molecule
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Molecule
Investment portfolio details for Molecule
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Molecule
Detailed financials for Molecule
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Molecule Comparisons
Peer comparison for Molecule
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Molecule
Molecule operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as OpenGamma, Realeyes, Moody's Analytics, Encompass and Indico Data, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
SaaS-based solutions for derivatives risk analytics are provided.
|
|
| Locked | Locked | Locked |
AI-powered attention measurement and identity verification solutions are provided.
|
|
| Locked | Locked | Locked |
Risk management software is supplied for insurance and various sectors.
|
|
| Locked | Locked | Locked |
Corporate Digital Identity and KYC solutions are provided by Encompass.
|
|
| Locked | Locked | Locked |
Data processing tasks are automated via AI-driven management solutions.
|
|
| Locked | Locked | Locked |
Cloud-based document and risk management software is offered for enterprises.
|
Detailed competitors of Molecule
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Molecule
Complete news archive for Molecule
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Molecule
Molecule was founded in 2012.
Molecule is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
Sameer Soleja is the current CEO of Molecule. They have also founded this company.
Molecule is a funded company, having raised a total of $14.34M across 5 funding rounds to date.
Molecule is established as a provider of cloud-native ETRMCTRM software, focusing on energy trading and risk management. Solutions are offered for various sectors including power, renewables, oil, gas, and crypto trading. The platform is designed to automate deal capture, provide real-time position and PL reporting, and support complex portfolios with scalable integrations. Industries served include independent power producers, hedge funds, and energy consumers, with specialized add-ons for renewables and physical power. Security and scalability are prioritized to ensure reliability across diverse trading environments.
Molecule's top competitors include Encompass, Indico Data and iManage.
Molecule offers Molecule ETRM/CTRM Platform, Renewables Add-on, Physical Power Add-on, and Crypto Add-on.
Molecule has 4 investors. Key investors include Mercury Fund, Houston Angel Network, Surge Ventures, and Sundance Growth.